Riverpoint Wealth Management Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
8,577
+78
| +0.9% | +$14.5K | 0.37% | 23 |
|
|
2025
Q1 | $1.78M | Buy |
8,499
+243
| +3% | +$50.9K | 0.46% | 21 |
|
|
2024
Q4 | $1.47M | Buy |
8,256
+75
| +0.9% | +$13.3K | 0.38% | 25 |
|
|
2024
Q3 | $1.62M | Buy |
8,181
+65
| +0.8% | +$12.8K | 0.41% | 24 |
|
|
2024
Q2 | $1.39M | Buy |
8,116
+77
| +1% | +$13.2K | 0.39% | 26 |
|
|
2024
Q1 | $1.46M | Buy |
8,039
+71
| +0.9% | +$12.9K | 0.41% | 24 |
|
|
2023
Q4 | $1.23M | Buy |
7,968
+84
| +1% | +$13K | 0.36% | 25 |
|
|
2023
Q3 | $1.18M | Buy |
7,884
+59
| +0.8% | +$8.79K | 0.39% | 23 |
|
|
2023
Q2 | $1.05M | Buy |
7,825
+60
| +0.8% | +$8.08K | 0.33% | 23 |
|
|
2023
Q1 | $1.24M | Buy |
7,765
+58
| +0.8% | +$9.24K | 0.43% | 21 |
|
|
2022
Q4 | $1.25M | Buy |
7,707
+53
| +0.7% | +$8.57K | 0.46% | 21 |
|
|
2022
Q3 | $1.03M | Buy |
7,654
+57
| +0.8% | +$7.65K | 0.44% | 21 |
|
|
2022
Q2 | $1.16M | Buy |
7,597
+52
| +0.7% | +$7.97K | 0.47% | 19 |
|
|
2022
Q1 | $1.22M | Buy |
7,545
+55
| +0.7% | +$8.92K | 0.42% | 21 |
|
|
2021
Q4 | $1.01M | Buy |
7,490
+57
| +0.8% | +$7.72K | 0.34% | 21 |
|
|
2021
Q3 | $802K | Buy |
7,433
+59
| +0.8% | +$6.37K | 0.28% | 26 |
|
|
2021
Q2 | $831K | Buy |
7,374
+60
| +0.8% | +$6.76K | 0.23% | 41 |
|
|
2021
Q1 | $791K | Buy |
7,314
+65
| +0.9% | +$7.03K | 0.24% | 41 |
|
|
2020
Q4 | $777K | Buy |
7,249
+61
| +0.8% | +$6.54K | 0.25% | 41 |
|
|
2020
Q3 | $630K | Buy |
7,188
+263
| +4% | +$23.1K | 0.23% | 44 |
|
|
2020
Q2 | $680K | Buy |
+6,925
| New | +$680K | 0.27% | 40 |
|